Arndt Hartmann mainly focuses on Pathology, Cancer research, Cancer, Internal medicine and Breast cancer. His Pathology research is multidisciplinary, incorporating elements of Bladder cancer and Fluorescence in situ hybridization. His Cancer research research incorporates elements of DNA methylation and Carcinogenesis, microRNA, Gene, Mutation.
His Cancer research is multidisciplinary, relying on both Molecular biology and Wnt signaling pathway. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Endocrinology and Oncology. In his research on the topic of Breast cancer, Cell cycle is strongly related with Bioinformatics.
Arndt Hartmann mostly deals with Internal medicine, Pathology, Oncology, Cancer research and Bladder cancer. His study ties his expertise on Gastroenterology together with the subject of Internal medicine. His research on Pathology frequently connects to adjacent areas such as Fluorescence in situ hybridization.
His research is interdisciplinary, bridging the disciplines of Proportional hazards model and Oncology. His work in Cancer research addresses subjects such as Epigenetics, which are connected to disciplines such as DNA methylation. His Bladder cancer research incorporates themes from Stage, Carcinoma in situ, Disease and Urology.
The scientist’s investigation covers issues in Internal medicine, Oncology, Cancer research, Bladder cancer and Pathology. His Breast cancer, Cohort, Clinical trial, Cancer and Chemotherapy investigations are all subjects of Internal medicine research. His research in Oncology intersects with topics in Stage, PD-L1 and Proportional hazards model.
His work deals with themes such as microRNA, Gene, Metastasis, Colorectal cancer and Tissue microarray, which intersect with Cancer research. His Bladder cancer research includes elements of Carcinoma in situ, Disease and Immune system. His study in Immunohistochemistry, Carcinoma, Malignancy and Biopsy falls within the category of Pathology.
His primary areas of investigation include Internal medicine, Bladder cancer, Oncology, Cancer research and Immunohistochemistry. His study looks at the relationship between Internal medicine and fields such as Gastroenterology, as well as how they intersect with chemical problems. His Oncology research includes themes of Cancer, Breast cancer, Immunotherapy, Clinical trial and Chemotherapy.
His work in Cancer research tackles topics such as DNA methylation which are related to areas like Chromatin. His Immunohistochemistry study is related to the wider topic of Pathology. Arndt Hartmann specializes in Pathology, namely Carcinoma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
A. Gordon Robertson;Jaegil Kim;Hikmat Al-Ahmadie;Joaquim Bellmunt.
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.
Jérôme Galon;Jérôme Galon;Jérôme Galon;Bernhard Mlecnik;Bernhard Mlecnik;Bernhard Mlecnik;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea;Helen K. Angell;Helen K. Angell;Helen K. Angell.
The Journal of Pathology (2014)
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
Franck Pagès;Bernhard Mlecnik;Florence Marliot;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea.
The Lancet (2018)
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
Xiaohong R. Yang;Jenny Chang-Claude;Ellen L. Goode;Fergus J. Couch.
Journal of the National Cancer Institute (2011)
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
Carsten Denkert;Gunter von Minckwitz;Silvia Darb-Esfahani;Bianca Lederer.
Lancet Oncology (2018)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley.
Nature Genetics (2013)
Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations.
Abbas Agaimy;Peter H Wünsch;Ferdinand Hofstaedter;Hagen Blaszyk.
The American Journal of Surgical Pathology (2007)
WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer.
Christoph Wissmann;Peter Johannes Wild;Simone Kaiser;Stefan Roepcke.
The Journal of Pathology (2003)
Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.
Alessandro Lugli;Richard Kirsch;Yoichi Ajioka;Fred Bosman.
Modern Pathology (2017)
Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: A mutational analysis with immunohistochemical correlation
Gad Singer;Robert Stöhr;Leslie Cope;Reiko Dehari.
The American Journal of Surgical Pathology (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: